Pancreatic ductal adenocarcinoma (PDAC) is associated with a pronounced collagen-rich fibrosis known as desmoplastic reaction; however, the role of fibrosis in PDAC is poorly understood. In this report we show that collagen can regulate the tumor suppressive let-7 family of microRNAs in pancreatic cancer cells. PDAC cells growing in 3D collagen gels repress mature let-7 without affecting the precursor form of let-7 in part through increased expression of membrane type 1-matrix metalloproteinase (MT1-MMP, MMP-14) and ERK1/2 activation. PDAC cells in collagen also demonstrate increased TGF-b1 signaling, and blocking TGF-b1 signaling attenuated collagen-induced MT1-MMP expression, ERK1/2 activation and repression of let-7 levels. Although MT1-MMP overexpression was not sufficient to inhibit let-7 on 2D tissue culture plastic, overexpression of MT1-MMP in PDAC cells embedded in 3D collagen gels or grown in vivo repressed let-7 levels. Importantly, MT1-MMP expression significantly correlated with decreased levels of let-7 in human PDAC tumor specimens. Overall, our study emphasizes the interplay between the key proteinase MT1-MMP and its substrate type I collagen in modulating microRNA expression, and identifies an additional mechanism by which fibrosis may contribute to PDAC progression.
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Keywords: TGF-b1; collagen; ERK1/2; MT1-MMP; let-7; fibrosis Human pancreatic ductal adenocarcinoma (PDAC) is frequently associated with an intense area of fibrosis known as the desmoplastic reaction (Jemal et al., 2007; Mahadevan and Von Hoff, 2007) . Desmoplastic reaction is composed of bands of fibrous stroma surrounding the malignant cells, whereas areas of relatively normal pancreas exhibit minimal fibrosis (Hezel et al., 2006; Ottaviano et al., 2006) . Human PDAC tumors exhibit increased amounts of type I collagen compared with normal pancreas and, with loss of basement membrane, the malignant cells are directly exposed to type I collagen (Imamura et al., 1995) . In human pancreatic tumor tissue, there is a strong correlation between the expression of TGF-b1 and type I collagen (Aoyagi et al., 2004) , and TGF-b1 overexpression in pancreatic cancer cells can induce desmoplatic reaction in an experimental model of human pancreatic carcinoma (Lohr et al., 2001 ).
Previously, we had shown that type I collagen modulated the behavior of PDAC cells by enhancing cell motility and increasing expression of membrane type 1-matrix metalloproteinase (MT1-MMP, MMP-14), a key collagenase that allows cells to invade through the collagen-rich extracellular matrix (Ottaviano et al., 2006) . MT1-MMP is overexpressed in pancreatic tumors mainly in areas of fibrosis, and expression of MT1-MMP is increased in metastatic PDAC lesions compared with the primary tumors. Animal studies support MT1-MMP as a primary regulator of interstitial collagenolysis, as mice genetically deficient in MT1-MMP have severe growth defects as a result of failure to process interstitial collagens during bone and soft tissue formation (Holmbeck et al., 1999; Zhou et al., 2000) . This conclusion is supported by in vitro studies using organotypic and 3D culture systems, which demonstrate that only MT1-MMP confers a 3D growth advantage by removing matrix confines and allowing changes in cellular geometry necessary for proliferation (Hotary et al., 2003; Sabeh et al., 2004) .
MicroRNAs are small single-stranded, non-coding RNAs that bind to target messenger RNA and inhibit translation or promote degradation of the transcript (Lewis et al., 2005; Lim et al., 2005) . A recent study showed that members of the let-7 family of microRNAs, initially identified as key regulators of embryonic development in Caenorhabditis elegans (Reinhart et al., 2000) , were decreased in human PDACs (Torrisani et al., 2009) . Let-7 expression increases with differentiation and is present in high levels in mature tissue (Erkan et al., 2007) , where it inhibits cell proliferation by monitoring DNA replication, mitosis and cytokinesis (Johnson et al., 2007) . Overexpression of let-7 in mutant K-Ras-positive lung-cancer cells inhibits tumor growth in vivo, whereas overexpression of let-7 in breast tumor-initiating cells inhibits tumor formation and metastasis in vivo (Yu et al., 2007) . Interestingly, K-Ras, which is mutated in 490% of PDAC, is also a target of let-7 microRNA (Johnson et al., 2005; Morris and McManus, 2005; Kumar et al., 2008) .
Although the collagen microenvironment has been shown to regulate gene expression, the extent to which the effect is mediated through modulation of microRNAs has not been previously examined. Therefore, in this study we examined the effect of collagen on let-7 family microRNAs. Initially, we examined the relative expression of the various members of the let-7 family of microRNAs in pancreatic cancer cells (Panc1) grown on tissue culture plastic. As shown in Supplementary  Figure 1 , there was differing expression of the various members of the let-7 family. Expression of let-7a and let-7e was most pronounced, let-7g and let-7i were in the intermediate range, whereas the relative levels of let-7c, let-7d, let-7f and miR-98 were significantly reduced. We next examined the effect of collagen on three members of let-7 family based on varying expression levels (let-7a, let-7d and let-7g). Panc1 cells were grown on 2D tissue culture plastic or embedded in 3D type I collagen gels for 24 h, and then processed for microRNA and messenger RNA expression. Compared with Panc1 cells grown on tissue culture plastic, Panc1 cells growing in 3D type I collagen gels show 80% reduction in the mature let-7 levels ( Figure 1a ) without affecting the expression of the precursor primary form of let-7 (Supplementary Figure 2) , indicating that collagen regulates the post-transcriptional processing of let-7 from the precursor form to the mature form. As type I collagen induces MT1-MMP expression in PDAC cells ( (Ottaviano et al., 2006) and Figure 1b) , we examined whether MT1-MMP may be involved in collagenrepression of let-7. Initially, we examined the effect of the broad-spectrum MMP inhibitor GM6001 on let-7 levels. As shown in Figure 1c , GM6001 partially rescued the effect of collagen on let-7 levels. Moreover, small interfering RNA knockdown of MT1-MMP also Figure 1 Collagen repression of let-7 microRNA involves MT1-MMP. Panc1 cells were grown on tissue culture plastic or in 3D type I collagen gels (5 mg/ml) in serum containing medium for 24 h. (a) MicroRNA were isolated using mirVana kit (Applied Biosystems, Foster City, CA, USA) and analyzed for expression of the mature let-7a, let-7d and let-7g by qRT-PCR, with RNU48 as the endogenous control, using gene specific Taqman probes (Applied Biosystems). The data were quantified by the comparative C T method for relative gene expression from three experiments. *Po0.05 relative to cells grown on plastic. (b) Similarly, MT1-MMP and GAPDH (endogenous control) mRNA were analyzed by qRT-PCR. *Po0.05 relative to cells grown on plastic. Data are an average from three separate experiments. (c) Panc1 cells were grown on plastic or in 3D type I collagen gels (5 mg/ml) and treated with either DMSO or GM6001 (10 mM; EMD, Gibbstown, NJ, USA) for 24 h. MicroRNA were isolated and analyzed for let-7 and RNU48 (endogenous control) expression by qRT-PCR. *Po0.05 relative to DMSO-treated cells grown in collagen. Data are an average of three separate experiments. (d) Panc1 cells were transiently transfected with siRNA against MT1-MMP or control siRNA (50 nmoles) using Nucleofector Kit R (Lonza, Walkersville, MD, USA). Cells were allowed to recover overnight and then plated on plastic or in collagen gels for 24 h. MT1-MMP knockdown was analyzed by immunoblotting for cells grown on plastic (upper panel), whereas microRNA were analyzed for let-7 and RNU48 (endogenous control) expression by qRT-PCR. *Po0.05; **Po0.01 relative to si Control transfected cells grown in collagen. Data are an average of three separate experiments.
Collagen represses let-7 microRNA S Dangi-Garimella et al partially rescued let-7 in 3D collagen (Figure 1d ), suggesting that collagen repression of let-7 is mediated in part through increased MT1-MMP expression.
As MT1-MMP has previously been shown to promote MEK/ERK1/2 activation (Sounni et al., 2010) , we examined the effect of MT1-MMP small interfering RNA on collagen-induced ERK1/2 phosphorylation. As shown in Figure 2a , decreasing MT1-MMP levels in Panc1 cells grown in 3D type I collagen-attenuated ERK1/2 phosphorylation (Figure 2a) . Moreover, collagen-induced ERK1/2 phosphorylation was mediated by MEK1/2 as U0126 completely blocked ERK1/2 activation ( Figure 2b) . However, the activation of ERK1/2 was independent of the epidermal growth factor receptor (EGFR). Treatment with EGFR inhibitors AG1478 or PD153035 did not inhibit collagenmediated ERK1/2 activation ( Figure 2c ). As ERK1/2 can repress let-7 levels (Dangi-Garimella et al., 2009) we examined the effect of ERK1/2 on collagen regulation of let-7. Panc1 cells growing on plastic or in 3D type I collagen were treated with vehicle control dimethyl sulfoxide (DMSO) or U0126 for 24 h. Treatment with U0126 significantly rescued the levels of mature let-7 in 3D collagen (Figure 2d ) without any effect on the precursor form of let-7 (Supplementary Figure 3) , demonstrating that collagen activates the MEK1/2-ERK1/2 signaling pathway to inhibit processing of let-7 to the mature form in pancreatic cancer cells. Our findings are consistent with a recently published study that showed a role for extracellular-signal-regulated kinases (ERK) in stabilizing the protein complex that regulates processing of precursor microRNAs (Paroo et al., 2009) . Specifically, mitogenic signaling-mediated ERK activation was shown to increase levels of growthpromoting microRNAs although decreasing expression of the tumor suppressor microRNAs let-7.
As we had previously shown that MT1-MMP expression involves TGF-b1 signaling in pancreatic cancer cells (Ottaviano et al., 2006) , we also examined whether TGF-b1 may have a role in collagen repression of let-7. Initially, we evaluated the effect of collagen on TGF-b1 signaling. As shown in Figures 3a and b , Panc1 cells growing in 3D type I collagen demonstrate a two-fold increase in TGF-b1 messenger RNA and increased Smad2 phosphorylation, which was blocked using a highly specific TGF-b type I receptor inhibitor SB431542. Significantly, treatment with SB431542 attenuated the effect of collagen on MT1-MMP, let-7 and Figure 1d . Cells were allowed to recover overnight and then plated in 3D type I collagen gels (5 mg/ml) for 24 h, the matrix was dissolved in collagenase (Worthington Biologicals, Lakewood, NJ, USA) and then lysed in m-RIPA buffer. Lysates were immunoblotted for ppERK1/2, ERK2 and a-tubulin (loading control). Data is representative of three separate experiments. (b) Panc1 cells were grown on tissue culture plastic or in 3D type I collagen gels (5 mg/ml) for 24 h and treated with vehicle control (DMSO) or U0126 (10 mM; Cell Signaling, Danvers, MA, USA) for 24 h. Cells grown in collagen were recovered with collagenase treatment and then lysed in m-RIPA buffer, before immunoblotting for ppERK1/2 and a-tubulin (loading control). Data is representative of four separate experiments. (c) Panc1 cells were grown on plastic or in 3D type I collagen gels (5 mg/ml) for 24 h and then treated with DMSO, AG1478 (10 mM; Calbiochem, Gibbstown, NJ, USA) or PD153035 (10 mM; Calbiochem) for an additional 24 h. Cells were lysed as before and then immunoblotted for ppERK1/2, ERK2 and a-tubulin (loading control). Data is representative of three separate experiments. (d) Panc1 cells grown on plastic or in collagen gels were treated with DMSO or U0126 for 24 h. MicroRNA were isolated using mirVana kit and analyzed for expression of let-7a, let-7d and let-7g by qRT-PCR, with RNU48 as the endogenous control, using gene-specific Taqman probes. The data were quantified by the comparative C T method for relative gene expression from four separate experiments. *Po0.05; **Po0.01 relative to DMSO-treated cells grown in collagen.
Collagen represses let-7 microRNA S Dangi-Garimella et al ERK1/2 phosphorylation (Figures 3c and d ). To directly demonstrate that TGF-b1 regulates let-7 expression, Panc1 cells grown on plastic were treated with recombinant human TGF-b1 for 24 h and let-7 expression was analyzed. As seen in Figure 3e , TGF-b1 treatment resulted in approximately 40% inhibition of let-7 expression. These results demonstrate that collagen, in part by enhancing TbRI activity, promotes MT1-MMP expression and ERK1/2 phosphorylation to repress let-7 in PDAC cells. We further evaluated the role of MT1-MMP in the regulation of let-7 expression by generating Panc1 cells expressing full-length or tail-less (DC) MT1-MMP protein. As the MT1-MMP protein without the tail is retained on the surface longer, there was increased MMP-2 activation by cells expressing the tail-less MT1-MMP protein compared with the wild-type MT1-MMP protein (Figure 4a ). Although overexpression of MT1-MMP was not sufficient to repress let-7 levels on plastic (data not shown), overexpression of MT1-MMP protein in PDAC cells grown in collagen further repressed let-7 levels compared with control PDAC cells (Figure 4b ). These results indicate that MT1-MMP repression of let-7 requires the collagen-milieu.
We next injected Panc1 cells into nude mice to examine whether MT1-MMP can modulate let-7 in vivo. Panc1-tet-V and Panc1-tet-DC cells were subcutaneously injected into the left and right flanks of nude mice, respectively, and the mice were maintained on doxycycline-containing water for 3 weeks to induce gene expression. The tumors were then collected and processed for messenger RNA and microRNA expression. For each mouse, the let-7 levels in the Panc1-tet-DC tumors were normalized to the matched Panc1-tet-V tumors, arbitrarily setting the let-7 in the Panc1-tet-V tumors to 1.0. As seen in Figure 4c , each DC-expressing tumor had lower levels of let-7 relative to the corresponding control tumor, indicating that MT1-MMP is also able to repress let-7 in vivo. Additionally, even though the effect was less pronounced compared with the DC-expressing tumors, Panc1 tumors expressing the wild-type MT1-MMP showed similar results, with lower levels of at least one of the let-7 family members in the MT1-MMPexpressing tumors relative to control tumors (Supplementary Figure 4 ). To provide additional support for our hypothesis that MT1-MMP can repress let-7 levels in the in vivo microenvironment, we examined the relationship between MT1-MMP and let-7 in human PDAC tumors (Figure 4d ). RNA and microRNA isolated from human PDAC tumor samples were analyzed for expression of MT1-MMP and let-7 and normalized to the adjacent matched normal pancreas. We found a statistically significant inverse relationship between MT1-MMP and let-7 (r ¼ À0.7091, P ¼ 0.0182).
Overall, in this report we show that PDAC cells growing in 3D type I collagen gels repress let-7 microRNA, in part through increased TGF-b1-mediated expression of MT1-MMP and ERK1/2 activation. It was recently shown that TGF-b1 can downregulate expression of miR-200 family members, and upregulate the oncogenic microRNA miR-21 (Qian et al., 2009) . We now provide evidence that TGF-b1 signaling can also regulate let-7 family members. Let-7 expression can inhibit pancreatic cancer-cell proliferation in vitro; however, let-7 did not affect progression of the primary tumor in vivo (Torrisani et al., 2009) . Interestingly, work done by Oh et al. suggests that let-7 could have therapeutic potential in the treatment of pancreatic cancer (Oh et al., 2010) . Expression of let-7 in A549 (lung cancer) and AsPC1 (pancreatic cancer) cells decreased K-Ras levels and potentiated the effect of radiation.
By gene signature analysis, additional microRNAs have also been shown to be differentially regulated between pancreatic cancer and normal pancreatic tissue or chronic pancreatitis (Bloomston et al., 2007) . Seven microRNAs (miR-21, miR-221, miR-222, miR-181a, b and d, and miR-155) were confirmed to be overexpressed in the tumor samples when compared with benign pancreatic tissue. Significantly, miR-155 can inhibit the pro-apoptotic p53 target protein TP53INP1, thus promoting PDAC progression (Gironella et al., 2007) . Fluorescence in situ hybridization analysis on tumor tissue microarrays also demonstrated that miR-21, which targets phosphatase and tensin homologue, is overexpressed in pancreatic cancer tissue relative to benign pancreatic lesions or chronic pancreatitis and is associated with poor outcome (Dillhoff et al., 2008) . . Panc1 cells inducibly expressing MT1-MMP were then generated as previously described (Dangi-Garimella et al., 2010) to create Panc1-tet-V, Panc1-tet-MT and Panc1-tet-DC. These cells were grown on plastic, induced with doxycycline (2 mg/ml) for 24 h, and then immunoblotted for MT1-MMP and a-tubulin (loading control) (upper panel). To examine MT1-MMP activity, the conditioned medium was analyzed for MMP-2 activation using gelatin zymography (lower panel). Data are representative of at least four separate experiments. (b) Panc1-tet-V, Panc1-tet-MT and Panc1-tet-DC cells were grown on tissue culture plastic or in 3D collagen gels (5 mg/ml), induced with doxycycline for 64 h and changes in let-7 and RNU48 (endogenous control) expression were analyzed by qRT-PCR from three separate experiments. *Po0.05 relative to control Panc1-tet-V cells. (c) Mice were housed, fed and treated in accordance with the guidelines approved by the Northwestern University IACUC. Athymic nu/nu animals (8-week old; n ¼ 8) were subcutaneously injected with 5 Â 10 6 Panc1-tet-V cells in the left flank and Panc1-tet-DC cells in the right flank of the same animal. Twenty four hours later, doxycycline was added to the drinking water to induce MT1-MMP expression, and monitored twice a week for the development of skin tumors. The mice were euthanized, following which the tumors were dissected and placed in RNAlater (Qiagen, Valencia, CA, USA). The RNAlater-preserved tumors were processed and analyzed for human MT1-MMP and human GAPDH mRNA or human let-7 and human sno135 microRNA expression by quantitative realtime PCR. For each animal the relative expression of let-7a, let-7d and let-7g was calculated in Panc1-tet-DC tumors and normalized to the levels present in the Panc1-tet-V tumors, with the let-7 expression in the control animals arbitrarily set at 1.0. Relative let-7 values o1.0 indicate repression by MT1-MMP. (d) Pancreatic tissue was obtained from patients with pancreatic adenocarcinoma and de-identified on an IRB-approved protocol. The cancerous and adjacent normal tissue samples were dissected and processed for RNA extraction using Trizol. The RNA quality was checked using Bioanalyzer-309 and samples with RNA Integrity Number (RIN) greater than six were used for RNA and microRNA studies. The let-7 levels relative to RNU48 and MT1-MMP expression relative to GAPDH in PDAC tumors (n ¼ 11) were normalized to the levels present in the matched adjacent normal pancreas, which was arbitrarily set at 1.0. Spearman's correlation (GraphPad Instat, GraphPad Software, La Jolla, CA, USA) was used to determine significance between MT1-MMP and let-7 levels in these tumors.
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